Condition: Hemophilia A · Sponsor: Octapharma
Recombinant factor VIII for the prevention of bleeding in women/girls with haemophilia A undergoing major surgery
This description comes directly from the study's public registry record.
Cristina Solomon · +41795859042 · cristina.solomon@octapharma.com
Always discuss trial participation with your own doctor first.
| UT Health San Antonio | San Antonio, Texas, United States | Recruiting |
| Helsinki University Hospital,Coagulation Disorder Unit | Helsinki, Finland | Recruiting |
| Avenue de la République | Chambray-lès-Tours, France | Recruiting |
| CHU de Nantes Hôtel-Dieu | Nantes, France | Recruiting |
| Chu de Strasbourg | Stasbourg, France | Not Yet Recruiting |
| Universitätsklinikum Bonn,Institut für Experimentelle Haematologie und Transfusionsmedizin | Bonn, Germany | Recruiting |
| Gerinnungszentrum Rhein-Ruhr | Duisburg, Germany | Recruiting |
| Universitätsklinikum Hamburg Eppendorf,II. Medizinische Klinik und Poliklinik | Hamburg, Germany | Recruiting |
| Aziendo Ospedaliera "Puglieze Ciaccio" | Catanzaro, Italy | Recruiting |
| Policlinico "P. Giaconne" | Palermo, Italy | Recruiting |
| Clinical Center for Serbia | Belgrade, Serbia | Recruiting |
| Hospital Universitario la Paz | Madrid, Spain | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05936580